Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients

With new agents entering the market, the sequencing of first-line (Tx1), second-line (Tx2), and subsequent chemotherapy/biologics regimens are being examined. We examined how Tx1 regimens impacted the likelihood of receiving Tx2 among metastatic colon cancer (mCC) patients. Surveillance, Epidemiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhiyuan, Hanna, Nader, Onukwugha, Eberechukwu, Reese, Emily S, Seal, Brian, Mullins, C Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930397/
https://www.ncbi.nlm.nih.gov/pubmed/24403130
http://dx.doi.org/10.1002/cam4.176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930397/
https://www.ncbi.nlm.nih.gov/pubmed/24403130
http://dx.doi.org/10.1002/cam4.176

Ejemplares similares